Navigation Links
CB1400, Patented by Canopus BioPharma, Enters Phase II Clinical Trials for the Prevention of Mucositis in Patients With Cancer of the Head and Neck
Date:6/23/2008

LOS ANGELES, June 23 /PRNewswire-FirstCall/ -- Canopus BioPharma, Inc. (OTC: CBIA), is pleased to announce that the South African Medicines Control Council has granted approval for a Phase II study in 30 cancer patients evaluating the protective effect of CB1400 on the gastrointestional tract from radiation-induced mucositis. This new trial is an important step forward in the development of CB1400 as a novel, preventative, anti-mucositis agent.

Oral and gastrointestinal (GI) mucositis is a painful, debilitating, and sometimes fatal, side-effect of radiation therapy and cancer chemotherapy. No preventative mucositis medicines are available, and few treatments are effective. With some cancer therapies, oral mucositis can develop in over 90% of patients. Consequently, it is a widespread problem with considerable economic and healthcare implications. There is a real need for an effective and well-tolerated mucositis prophylactic. The US market for a preventative mucositis agent is estimated to be over $1 billion per annum.

In work carried out on behalf of Canopus, CB1400 has already been shown to have protective and antimutagenic effects when tested in an animal model of mucositis. Complete protection of the GI tract was seen in gamma-radiated mice pre-treated with oral CB1400 (100 mg/kg/day). Even with high doses of radiation (10Gy), there was no evidence of mucositis: weight gain was observed in the CB1400 pre-treated groups; all mice treated with placebo died.

Canopus BioPharma Inc. has applied to undertake further clinical studies with leading oncologists in Australia, South Africa and the USA, investigating CB1400 as a preventative mucositis agent in head and neck cancer patients who are receiving radiation and/or chemotherapy.

About Canopus BioPharma, Inc.:

Canopus BioPharma, Inc. (OTCBB: CBIA) is dedicated to providing the safest, most cost effective and efficacious pharmaceutical products and assay methods in the areas o
'/>"/>

SOURCE Canopus BioPharma, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Impliant Restarts Pivotal Clinical Trial for Patented TOPS(TM) Spine System
2. ArtJen Announces Major Clinical Trial of Its Patented Weight Loss Product FBCx
3. Canopus BioPharma Strengthens its CB1400 Platform Technology for Mucositis and Oncology Treatments Through License Agreement With Wisconsin Alumni Research Foundation
4. Victory Pharma, Inc. Reports MGX006 Enters Into Pivotal Development Program
5. Bavarian Nordic Enters Clinical Trials with HIV Multiantigen Vaccine
6. Ovarian Cancer Vaccine Clinical Trial Begins at Cancer Treatment Centers of America
7. Top Academic Medical Centers, Research Institutions, and Partners Gather, Share Experiences and Success Stories at Velos eResearch Annual Meeting
8. World Renowned Cancer Centers Implore Americans to Donate $1 to Make Change and Accelerate Cancer Research
9. Alseres Pharmaceuticals Enters Agreement to Amend Cethrin(R) License to Lower Milestone Payments and Royalty Rates
10. ESBATechs Lead Antibody Fragment Enters Clinical Development for Ophthalmic Indications
11. STAR Cranial Centers of Excellence Offer Cutting-Edge Treatment to Dallas Area Children
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... , Aug. 21, 2014 InfinityQS International, ... Manufacturing Intelligence , today announces Infusion Chicago, ... event will be held Oct. 9-10, 2014, at ... designed to showcase the necessity for implementing a ... and Manufacturing Intelligence to gain insight into production ...
(Date:8/21/2014)... ROCHESTER, N.Y. , Aug. 21, 2014  The ... VSCP ), a leading provider of clinical trial imaging ... has been named chief financial officer, effective immediately.  Mr. ... officer since August 2013.  He joined VirtualScopics in January ... controller in February 2013. "When the board ...
(Date:8/21/2014)...  Cyberonics, Inc. (NASDAQ: CYBX ) today announced ... Quarterly highlights 1   Operating results for ... quarter of fiscal 2014, and other achievements, include: , ... 6.8%; , Strong international net sales of $13.2 million, ... , U.S. net product sales reached a new high of ...
Breaking Medicine Technology:InfinityQS to Host Manufacturing Intelligence Conference in Chicago 2VirtualScopics, Inc. Names James Groff Chief Financial Officer 2VirtualScopics, Inc. Names James Groff Chief Financial Officer 3VirtualScopics, Inc. Names James Groff Chief Financial Officer 4Cyberonics Reports Fiscal 2015 First Quarter Results 2Cyberonics Reports Fiscal 2015 First Quarter Results 3Cyberonics Reports Fiscal 2015 First Quarter Results 4Cyberonics Reports Fiscal 2015 First Quarter Results 5Cyberonics Reports Fiscal 2015 First Quarter Results 6Cyberonics Reports Fiscal 2015 First Quarter Results 7Cyberonics Reports Fiscal 2015 First Quarter Results 8Cyberonics Reports Fiscal 2015 First Quarter Results 9Cyberonics Reports Fiscal 2015 First Quarter Results 10Cyberonics Reports Fiscal 2015 First Quarter Results 11Cyberonics Reports Fiscal 2015 First Quarter Results 12Cyberonics Reports Fiscal 2015 First Quarter Results 13Cyberonics Reports Fiscal 2015 First Quarter Results 14Cyberonics Reports Fiscal 2015 First Quarter Results 15Cyberonics Reports Fiscal 2015 First Quarter Results 16
(Date:8/21/2014)... The “Proteomics Market by Technology (Protein ... Plasmon Resonance, X-ray Crystallography) - Instruments, Reagents & ... studies the major market drivers, restraints, and opportunities ... of the World (RoW) , Browse 138 market ... and in-depth TOC on “Proteomics Market by Technology ...
(Date:8/21/2014)... Top10BestSEOHosting.com has recently compared many professional web ... ) is one of the best cheap web ... of Top10BestSEOHosting.com states, “It is hard to find ... have outperformed their competitors on hosting features, uptime, ... the best web hosting at affordable prices.” ...
(Date:8/21/2014)... 2014 An increasing amount of complaints ... their federal tax payment is being returned by their ... from the IRS, “tax@irs.gov”, it’s actually a phishing tactic ... financial information. , While similar scams have been going ... phishing activity is occurring right now. , First, ...
(Date:8/21/2014)... laryngeal cancer appear to have better survival if ... , Author: Uchechukwu C. Megwalu, M.D., M.P.H., of ... New York, and colleagues. , Background: Approximately 11,000 ... each year and squamous cell carcinoma accounts for ... 1991, total surgical removal of the larynx with ...
(Date:8/21/2014)... a low or very low birth weight may be ... The findings, which appear in Diabetes Care , ... 2 diabetes in African American populations, which has a ... Boston University,s Slone Epidemiology Center followed more than 21,000 ... the course of 16 years, analyzing characteristics such as ...
Breaking Medicine News(10 mins):Health News:Proteomics Market worth $20,696.4 Million by 2018 - New Research Report by MarketsandMarkets 2Health News:Proteomics Market worth $20,696.4 Million by 2018 - New Research Report by MarketsandMarkets 3Health News:Proteomics Market worth $20,696.4 Million by 2018 - New Research Report by MarketsandMarkets 4Health News:Proteomics Market worth $20,696.4 Million by 2018 - New Research Report by MarketsandMarkets 5Health News:iPage Reviews Unveiled Online At Top10BestSEOHosting.com 2Health News:Beware Of Phony “Tax Payment Rejected” IRS Emails 2Health News:Surgery associated with better survival for patients with advanced laryngeal cancer 2Health News:Low birth weight linked to higher incidence of type 2 diabetes in African American women 2
... suggests they,re less likely to separate reality from fiction ... adult-themed movies and television shows as children become sexually active ... Boston study finds. , It included 754 participants who were ... were aged 12 to 18. The earlier in their life ...
... to End Prostate Cancer to Take Strides for the CauseWASHINGTON, May ... runners are hitting the pavement to ramp up their running regimes ... Prostate Cancer has joined forces with the ING New York City ... formed a team to run in the race on Nov. 1. ...
... FY 2010 Proposed Medicare Cut Weakens Key Health Care ... Mo., May 4 The Coalition to Protect Senior ... a Medicare regulation put forward for implementation Friday by ... proposed Medicare rule, a Coalition spokeswoman said, would cut ...
... Show Increase In Searches, Social Media "Chatter," As Consumers Seek ... Add nose washing to the steps that ... hand washing and coughing in a tissue -- in an ... Google Insights For Search, "neti pot" increased as a search ...
... Physicians to Make the Most Informed Decisions When Time ... Medical Technologies continues to add to its portfolio of ... the tools necessary to make critical decisions regarding a ... recent participation in the Integrating the Healthcare Enterprise (IHE) ...
... The Illinois Soybean Association (ISA ) is ... (GCNF) in Cape Town , South ... of people from around the world will be participating in the ... CW Gaffner and Pat Dumoulin - will represent Illinois farmers and ...
Cached Medicine News:Health News:Viewing Adult-Themed TV Tied to Earlier Sex for Teens 2Health News:Team ZERO to Run to End Prostate Cancer in 2009 ING New York City Marathon 2Health News:Nation's Front Line Caregivers Mobilizing to Help Defeat Obama Implementation of Damaging Medicare Regulation 2Health News:Along With Hand Washing and Covering Up When Coughing, Add Nose Washing to Steps Consumers Looking to Take for Flu Prevention 2Health News:Greenway Medical Technologies' PrimeSuite Solution Provides OB/GYN Physicians With Instant Access to Labor and Delivery Information at Point-of-Care 2Health News:Greenway Medical Technologies' PrimeSuite Solution Provides OB/GYN Physicians With Instant Access to Labor and Delivery Information at Point-of-Care 3Health News:Greenway Medical Technologies' PrimeSuite Solution Provides OB/GYN Physicians With Instant Access to Labor and Delivery Information at Point-of-Care 4Health News:Illinois Soybean Association to Participate in Global Child Nutrition Forum in South Africa 2
... controlled, Blanketrol II total body ... effective patient warming and/or cooling ... Blanketrol II offers the largest ... of any hyper-hypothermia system providing ...
... Zeiss is expanding the borders of ... excellent color reproduction, high-contrast images and ... optics provide improved resolution and contrast. ... Control Panel) combines all essential functions ...
Inquire...
Compact tray features all components for urethral catheterization....
Medicine Products: